Kim Orchard

9PUBLICATIONS
44CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Instruments and techniquesRadiation therapyRespiratory diseasesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 06, 2026
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party.

Gesine Bug, Myriam Labopin, Jennifer L Byrne

|Mar 04, 2026
Correction: Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation.

Kim Orchard, Jonathan Langford, Matthew Guy

|Jun 12, 2024
Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation.

Kim Orchard, Jonathan Langford, Matthew Guy

|Jan 09, 2023
Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study.

Joshua A Fein, Roni Shouval, Jacques-Emmanuel Galimard

|Jun 02, 2022
The impact of COVID-19 on related-donor allogeneic stem cell harvest processes: A British Society of Blood and Marrow Transplantation and Cellular Therapy survey.

Julia Wolf, Julia Lee, Rachel Pearce

|Oct 06, 2021
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.

Maria A V Marzolini, Varun Mehra, Kirsty J Thomson

Pageof 2

Frequent Collaborators

3 joint publications

John A Snowden

2 joint publications

Stephanie Jordaens

2 joint publications

Viggo Van Tendeloo

2 joint publications

Ken I Mills